Evogene stock heads into Q3 results call on November 19

Evogene said on November 5 that it will publish its third-quarter 2026 financial results on November 19, followed by a management conference call at 9:00 a.m. Eastern Time. The schedule was reported by Nasdaq.

Results date sets the next catalyst

The release will give investors the next formal update on Evogene's operations and finances. Management plans to discuss the results during the same-day call, with the webcast to be made available on the company's website afterward.

Evogene is also due to participate in BIO-Europe in Cologne from November 9 to 11 and Drug Discovery Chemistry Europe in Barcelona from November 10 to 12. Its investor-relations page says the company will use these events to present its technology and engage with potential partners.

Computational chemistry focus

Evogene develops generative artificial intelligence for designing and optimizing small molecules for pharmaceutical and agricultural applications. Its ChemPass AI platform explores chemical space and supports both strategic partnerships and internal product development, according to the company's Investor Relations page. The company is headquartered in Rehovot, Israel, and trades on Nasdaq and the Tel Aviv Stock Exchange.